On September 26, the European Researchers’ Night was celebrated across hundreds of cities in Europe. Once again, VHIO joined the…
The ODELIA consortium came together in Barcelona for its annual face-to-face meeting, hosted by the Vall d’Hebron Institute of Oncology…
On the occasion of World Cancer Research Day, held every September 24, the Vall d’Hebron Institute of Oncology (VHIO) reaffirms…
”la Caixa” Foundation has announced the results of the 2025 CaixaImpulse program, supporting 31 biomedical projects from research centers, hospitals,…
At the PRECISEU General Assembly, held during the Life Sciences Baltics Conference in Vilnius, Lithuania, the innovative project PragmaTIL was…
Dr. Pedro Rocha, medical oncologist at Vall d’Hebron University Hospital and researcher of VHIO’s Thoracic Tumors Group, has been awarded…
Results from the international Phase 1/2 clinical trial ARROS-1 show promising outcomes with zidesamtinib, a novel ROS1 selective inhibitor under…
Dr. Irene Casanova, senior researcher in VHIO’s Prostate Cancer Research Group, has been awarded a Starting Grant from the European…
The Vall d’Hebron Institute of Oncology (VHIO) and the CaixaResearch Institute are joining forces to host a dedicated ERC InfoDay…
In a world where healthcare systems are under pressure, can artificial intelligence (AI) help doctors make faster, smarter decisions and…
The Vall d’Hebron Institute of Oncology (VHIO) has officially become a core member of Cancer Prevention Europe (CPE)—a major milestone…
